Brief: Active Biotech Announces Outcome Of Rights Issue

Active Biotech AB publ

11/12/2025 08:04

Dec 11 (Reuters) - Active Biotech AB ACTI.ST:

SAID ON WEDNESDAY RIGHTS ISSUE HAS BEEN SUBSCRIBED TO A TOTAL OF APPROXIMATELY 82.8 PERCENT

75.5 PERCENT WERE SUBSCRIBED WITH SUBSCRIPTION RIGHTS AND ABOUT 7.3 PERCENT WERE SUBSCRIBED WITHOUT SUBSCRIPTION RIGHTS

ABOUT 17.3 PERCENT OF THE RIGHTS ISSUE WILL BE ALLOCATED TO THE INVESTORS THAT HAVE GUARANTEED THE RIGHTS ISSUE

BOARD OF DIRECTORS HAS CHOSEN NOT TO EXERCISE THE OVER-ALLOTMENT OPTION OF A MAXIMUM OF SEK 10.0 MILLION

THROUGH THE RIGHTS ISSUE, ACTIVE BIOTECH RECEIVES APPROXIMATELY SEK 70.3 MILLION BEFORE ISSUING COSTS

 Source text for Workspace: ID:nMFN36mtvr
 Further company coverage: ACTI.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))